Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul;190(1):e27-e29.
doi: 10.1111/bjh.16814. Epub 2020 Jun 9.

Reflection on passive immunotherapy in those who need most: some novel strategic arguments for obtaining safer therapeutic plasma or autologous antibodies from recovered COVID-19 infected patients

Francesco Lanza  1 , Jerard Seghatchian  2
Affiliations

Reflection on passive immunotherapy in those who need most: some novel strategic arguments for obtaining safer therapeutic plasma or autologous antibodies from recovered COVID-19 infected patients

Francesco Lanza et al. Br J Haematol. 2020 Jul.
No abstract available

PubMed Disclaimer

References

    1. Burnouf T, Seghatchian J. Ebola virus convalescent blood products: where we are now and where we may need to go. Transfus Apher Sci. 2014;51(2):120–5. 10.1016/j.transci.2014.10.003 - DOI - PMC - PubMed
    1. WHO . Use of convalescent whole blood or plasma collected from patients recovered from Ebola virus disease for transfusion, as an empirical treatment during outbreaks. 2014. 2020. Available from: http://apps.who.int/iris/rest/bitstreams/604045/retrieve (accessed Feb 20, 2020).
    1. Casadevall A, Pirofski LA. The convalescent sera option for containing COVID‐19. J Clin Invest. 2020;130(4):1545–8. 10.1172/JCI138003 - DOI - PMC - PubMed
    1. Chen L, Xiong J, Bao L, Shi Y. (2020) Convalescent plasma as a potential therapy for COVID‐19. Lancet Infect Dis. 2020;20(4):398–400. 10.1016/S1473-3099(20)30141-9 - DOI - PMC - PubMed
    1. Seghatchian J, Lanza F. Convalescent plasma, an apheresis research project by targeting and motivating the fully recovered COVID 19 patients: a rousing message of clinical benefits to both donors /recipients alike. Transfus Apher Sci. 2020;2020. 10.1016/j.transci.2020.102794 - DOI - PMC - PubMed